FAQ/Help |
Calendar |
Search |
Today's Posts |
11-10-2009, 09:59 PM | #1 | ||
|
|||
Senior Member
|
Whoa, did anyone see this? Fox awarded research $$$ for naltrexone! Woo-hoo! Also note the funding for transcranial magnetic stimulation, something discussed here on the forum recently. Here's the link:
http://www.earthtimes.org/articles/s...,1038520.shtml Last edited by lurkingforacure; 11-10-2009 at 10:00 PM. Reason: addition of material |
||
Reply With Quote |
11-10-2009, 10:14 PM | #2 | |||
|
||||
Senior Member
|
what great news. hopefully measurements to determine progression (or lack thereof) of symptoms will be undertaken, even though that is not the study question.
Wish someone would take at look at Ibogaine/Ibocaine for its ability to stimulate GDNF activity. http://neurotalk.psychcentral.com/sh...d.php?p=307040
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
Reply |
Thread Tools | |
Display Modes | |
|
|
Similar Threads | ||||
Thread | Forum | |||
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. | Multiple Sclerosis | |||
what's a clinical trial like? | Parkinson's Disease | |||
Cere 120 clinical trial | Parkinson's Disease | |||
CLINICAL TRIAL...Phase III Trial with Pimavanserin in Patients with PD Psychosis | Parkinson's Disease Clinical Trials |